Select Language

English

Down Icon

Select Country

France

Down Icon

Moselle. Essure Contraceptive Implant and Side Effects: A Legal Information Meeting for Victims in Metz This Thursday

Moselle. Essure Contraceptive Implant and Side Effects: A Legal Information Meeting for Victims in Metz This Thursday

The Resist association is organizing a legal information meeting in Metz this Thursday to support women who have been victims of the Essure contraceptive implant, a medical device responsible for serious adverse effects in thousands of users in France. In collaboration with a law firm and a litigation funder, the association intends to have the women's injuries recognized in court.
Essure, a micro-implant that blocks the fallopian tubes, has caused adverse effects in many patients. The product has been discontinued since 2018. Photo by Anthony Picore
Essure, a micro-implant that blocks the fallopian tubes, has caused adverse effects in many patients. The product has been discontinued since 2018. Photo by Anthony Picore

The leaders of the Resist association (Mutual Aid, Support and Information Network on Tubal Sterilization) have begun a tour of France to meet women who have been victims of the Essure contraceptive implant. This medical device causes serious adverse effects in thousands of carriers in France . This Thursday, June 12, at 6 p.m., the association is organizing a legal information meeting at the Novotel Metz center, Place des Paraiges. You can register or participate by videoconference via the Resist website .

This content is blocked because you have not accepted cookies and other trackers.

By clicking on "I accept" , cookies and other trackers will be placed and you will be able to view the contents ( more information ).

By clicking on "I accept all cookies" , you authorize the deposit of cookies and other tracers for the storage of your data on our sites and applications for the purposes of personalization and advertising targeting.

You can withdraw your consent at any time by consulting our data protection policy . Manage my choices

"The goal is to explain the strategy developed to have Essure victims recognized as victims. We are raising awareness among women; some are unaware that the implant is the cause of their suffering. In partnership with the law firm JVL and the litigation financing company Litfin, we launched this legal support initiative, which has already brought together more than 500 complaint files," explains Clara Wauquiez, the association's secretary general. Marielle Klein, from Spicheren near Forbach , was one of the whistleblowers regarding this contraceptive implant. The woman from Moselle will be present at the meeting in Metz to share her story.

This content is blocked because you have not accepted cookies and other trackers.

By clicking on "I accept" , cookies and other trackers will be placed and you will be able to view the contents ( more information ).

By clicking on "I accept all cookies" , you authorize the deposit of cookies and other tracers for the storage of your data on our sites and applications for the purposes of personalization and advertising targeting.

You can withdraw your consent at any time by consulting our data protection policy . Manage my choices

This content is blocked because you have not accepted cookies and other trackers.

By clicking on "I accept" , cookies and other trackers will be placed and you will be able to view the contents ( more information ).

By clicking on "I accept all cookies" , you authorize the deposit of cookies and other tracers for the storage of your data on our sites and applications for the purposes of personalization and advertising targeting.

You can withdraw your consent at any time by consulting our data protection policy . Manage my choices

Essure, a permanent contraceptive device marketed by Bayer, was implanted in 200,000 French women between 2002 and 2017. Several thousand of them reported serious adverse effects to the ANSM (French National Agency for the Safety of Medicines) such as chronic fatigue, memory loss, speech difficulties, neurological disorders, muscle and joint pain, etc. Already, more than 30,000 of them have had the implant removed, requiring major surgery. In 2017, the device lost its marketing authorization in Europe. Since 2018, it has no longer been marketed in any country. The women victims now want official recognition in the courts.

Le Républicain Lorrain

Le Républicain Lorrain

Similar News

All News
Animated ArrowAnimated ArrowAnimated Arrow